|
C14ORF33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.316600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.625670E-04 |
| Normal-vs-Stage2 |
1.408420E-01 |
| Normal-vs-Stage3 |
5.476000E-01 |
| Normal-vs-Stage4 |
1.320020E-01 |
| Stage1-vs-Stage2 |
4.365600E-01 |
| Stage1-vs-Stage3 |
1.006770E-01 |
| Stage1-vs-Stage4 |
1.447930E-02 |
| Stage2-vs-Stage3 |
4.810400E-01 |
| Stage2-vs-Stage4 |
1.772310E-02 |
| Stage3-vs-Stage4 |
6.090100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.178600E-03 |
| Normal-vs-AfricanAmerican |
2.963800E-03 |
| Normal-vs-Asian |
4.746200E-01 |
| Caucasian-vs-AfricanAmerican |
4.419400E-01 |
| Caucasian-vs-Asian |
1.942640E-01 |
| AfricanAmerican-vs-Asian |
6.797700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.589700E-04 |
| Normal-vs-Female |
6.753200E-01 |
| Male-vs-Female |
1.592260E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.508500E-02 |
| Normal-vs-Extreme_Weight |
2.26229999999994E-05 |
| Normal-vs-Obese |
4.773000E-01 |
| Normal-vs-Extreme_Obese |
1.163430E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.077700E-02 |
| Normal_Weight-vs-Obese |
3.751200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.675440E-01 |
| Extreme_Weight-vs-Obese |
7.858100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.444400E-01 |
| Obese-vs-Extreme_Obese |
1.523610E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.908000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.610350E-02 |
| Normal-vs-Age(61-80Yrs) |
9.424900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.152500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.657190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.043180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.647800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.843800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.190560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.774400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.161300E-03 |
| Normal-VS-Type2 PRCC |
1.428090E-02 |
| Normal-VS-KIRP CIMP |
9.953900E-02 |
| Normal-VS-Unclassified PRCC |
5.944100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.821600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.000300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.986200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.673800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.198800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.294300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.219900E-03 |
| Normal-vs-N1 |
1.662570E-01 |
| Normal-vs-N2 |
2.179400E-01 |
| N0-vs-N1 |
1.088440E-02 |
| N0-vs-N2 |
8.851400E-01 |
| N1-vs-N2 |
2.916200E-01 |
|
|
